SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-015898
Filing Date
2023-12-05
Accepted
2023-12-05 18:26:20
Documents
2
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 form4-12052023_111210.html 4  
1 form4-12052023_111210.xml 4 8204
2 ex24-12052023_111210.htm EX-24 4945
  Complete submission text file 0001415889-23-015898.txt   14600
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 30 BLUE HERON DR. GREENWOOD VILLAGE CO 80121
Business Address
Scott John K Jr. (Reporting) CIK: 0001753763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 231467972